Nattokinase: The Definitive Guide

What is nattokinase?

Nattokinase is a subtilisin-family enzyme isolated from natto, fermented soybeans made with Bacillus subtilis var. natto. Supplements may remove vitamin K2 and standardize activity in fibrinolytic units (FU).

Nattokinase is not the same as natto food, vitamin K2 or a prescription thrombolytic. Laboratory clot breakdown does not prove prevention or treatment of heart attack, stroke or venous thrombosis.

Typical Nattokinase Protocols

No RDA, AI or UL exists. A label should state FU per serving and serving frequency; do not convert FU from milligrams.

Enzyme activity

Record FU per capsule and per day. Equal milligram amounts may have different activity.

Vitamin K2 status

Record whether K2 was removed; this matters when comparing natto food, products and anticoagulant context.

Endpoint

Separate an eight-week pressure change from three-year carotid progression or acute clot treatment.

Bleeding context

Record anticoagulants, antiplatelets, bleeding disorders, procedures and unexplained bruising.

What is nattokinase commonly used for?

It is marketed for circulation, blood pressure, “clot support,” lipids and arterial health. Evidence does not support using it to treat a suspected clot, replace an anticoagulant or prevent a cardiovascular event.

Short BP findings are modest and inconsistent with the longer NAPS result. The absence of carotid progression benefit is especially relevant to broad “artery cleaning” claims.

Which forms and labels matter?

Look for FU per capsule, FU per daily serving, enzyme identity, K2 status, soy allergen disclosure and independent quality testing. “2,000 FU” and “100 mg” describe different properties; both may appear, but activity is the more informative comparison.

What does the human evidence show?

NAPS randomized 265 adults without clinical cardiovascular disease to nattokinase 2,000 FU daily or placebo. After a median three years, annual change in carotid intima-media thickness and stiffness did not differ. Blood pressure, metabolic measures, coagulation and fibrinolysis factors, inflammation and cellular activation markers were also neutral. [1]

Kim randomized 86 adults with untreated systolic pressure of 130–159 mmHg; 73 completed eight weeks. One 2,000-FU capsule daily produced net changes versus placebo of −5.55 mmHg systolic and −2.84 mmHg diastolic. The attrition and short duration limit certainty, and the result does not show fewer events. [2]

Li pooled six randomized trials with 546 participants. Mean differences favored nattokinase by 3.45 mmHg systolic and 2.32 mmHg diastolic. Lipids did not improve; some estimates were unfavorable, and glucose rose slightly. Trial count and duration remain limited. [3]

How might nattokinase work?

Nattokinase degrades fibrin in laboratory systems and may influence fibrinolytic and coagulation pathways. Oral absorption of intact active enzyme and translation to clinical thrombosis outcomes remain uncertain. A mechanistic effect on clot-related markers is not proof of safe clot prevention.

What are the risks and interactions?

Bleeding is the central concern. Anticoagulants, antiplatelet drugs, thrombolytics, NSAIDs, bleeding disorders and surgery can change risk. Never replace prescribed anticoagulation with nattokinase. Seek urgent care for signs of stroke, pulmonary embolism, deep-vein thrombosis, major bleeding or head injury.

Soy allergy may apply, depending on purification and residual protein. Pregnancy, breastfeeding, pediatric use and long-term use in high-risk patients are inadequately studied.

Legal status in the United States and Canada

In the United States, nattokinase is sold as a dietary supplement and is not approved to treat thrombosis, hypertension or atherosclerosis.

In Canada, authorized natural health products have product-specific conditions. A licence does not establish equivalence to the NAPS material or authorize replacement of antithrombotic care.

What should be monitored?

Record FU per administration, frequency, product, K2 status, blood pressure method, bruising, bleeding, procedures and all medicines. Clinician-directed coagulation tests do not automatically capture every supplement effect.

What happens after stopping?

No withdrawal syndrome or standard taper is established. A prescriber should direct any change made around anticoagulation, antiplatelet treatment or surgery.

How should it be stored?

Follow the label, including any temperature or moisture instructions for enzyme activity. Keep the lot and expiry information and store away from children.

Community experiences

Anecdotes often omit FU, K2 status and concurrent aspirin or anticoagulants. They cannot establish clot prevention or rule out bleeding risk.

How does nattokinase compare with other approaches?

Anticoagulants and antiplatelet drugs have defined indications, standardized dosing and clinical-outcome evidence. Nattokinase does not have evidence to replace them. Hypertension care also uses validated measurements and outcome-based therapy rather than enzyme activity claims.

Frequently asked questions

Are 2,000 FU and 100 mg the same thing?

No. FU measures activity; mg measures mass. A particular product may declare both.

Did NAPS slow carotid atherosclerosis?

No. The three-year randomized trial was neutral for carotid progression and other measured outcomes. [1]

What exact schedule did Kim use?

One capsule containing 2,000 FU daily for eight weeks. [2]

Does nattokinase dissolve clots in people?

The cited trials do not establish treatment of an acute clot.

Can it replace an anticoagulant?

No. Stopping prescribed anticoagulation can be dangerous.

Can it be taken before surgery?

Disclose it early to the surgical team because bleeding risk and stopping timing require clinical direction.

Glossary

Terms used in this guide.

Fibrinolytic unit (FU)

An assay-based unit of enzyme activity; it is not a mass unit.

Fibrin

A protein mesh that helps form blood clots.

Carotid intima-media thickness

An ultrasound measure used as a marker of subclinical arterial change.

Fibrinolysis

The biological process that breaks down fibrin clots.

Anticoagulant

A medicine that reduces formation or extension of blood clots through defined pathways.

Natto

Fermented soybean food that can contain nattokinase and vitamin K2.

How this guide was researched

This draft prioritizes the long NAPS trial, then contrasts it with an exact short BP protocol and the current randomized-trial meta-analysis. Evidence was updated October 9, 2026.

How this guide was made

The ledger preserves FU, mass, frequency, duration, population, endpoint, attrition, access level and correction status.

Sources

Related guides